Total Payments
$22,750
2024 Payments
$99.99
Companies
24
Transactions
164
Medicare Patients
28,543
Medicare Billing
$2.6M
Payment Breakdown by Category
Consulting$11,100 (48.8%)
Other$6,100 (26.8%)
Food & Beverage$3,197 (14.1%)
Travel$1,095 (4.8%)
Research$1,000 (4.4%)
Education$258.18 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,100 | 3 | 48.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,100 | 2 | 26.8% |
| Food and Beverage | $3,197 | 144 | 14.1% |
| Travel and Lodging | $1,095 | 10 | 4.8% |
| Unspecified | $1,000 | 2 | 4.4% |
| Education | $258.18 | 3 | 1.1% |
Payments by Type
General
$21,750
162 transactions
Research
$1,000
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $19,501 | 35 | $0 (2022) |
| LEO Pharma AS | $1,000 | 2 | $0 (2019) |
| Janssen Biotech, Inc. | $470.33 | 20 | $0 (2024) |
| AbbVie Inc. | $414.50 | 24 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $341.97 | 21 | $0 (2020) |
| Amgen Inc. | $248.65 | 12 | $0 (2020) |
| PFIZER INC. | $152.99 | 12 | $0 (2019) |
| GENZYME CORPORATION | $145.17 | 7 | $0 (2021) |
| Lilly USA, LLC | $86.40 | 7 | $0 (2019) |
| Galderma Laboratories, L.P. | $65.70 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.99 | 1 | Janssen Biotech, Inc. ($99.99) |
| 2023 | $94.99 | 1 | Janssen Biotech, Inc. ($94.99) |
| 2022 | $59.09 | 4 | Allergan, Inc. ($59.09) |
| 2021 | $39.26 | 2 | GENZYME CORPORATION ($25.14) |
| 2020 | $238.73 | 13 | AbbVie Inc. ($67.60) |
| 2019 | $1,332 | 38 | LEO Pharma AS ($750.00) |
| 2018 | $827.17 | 36 | LEO Pharma AS ($250.00) |
| 2017 | $20,059 | 69 | Allergan Inc. ($19,428) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 06/01/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 10/07/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/22/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/01/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/04/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/05/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/17/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Immunology | ||||||
| 11/11/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2020 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Immunology | ||||||
| 10/04/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Immunology | ||||||
| 08/27/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/14/2020 | Galderma Laboratories, L.P. | AKLIEF (Drug), SOOLANTRA | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: ACNE | ||||||
| 03/09/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Immunology | ||||||
| 02/17/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Inflammation | ||||||
| 02/10/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: IMMUNOLOGY | ||||||
| 01/27/2020 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 01/13/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2019 | Amgen Inc. | Otezla (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Inflammation | ||||||
| 12/02/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Immunology | ||||||
| 11/12/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROTOPIC APPLES | LEO Pharma AS | $1,000 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 6,354 | 14,386 | $1.6M | $575,104 |
| 2022 | 27 | 8,114 | 17,604 | $2.0M | $763,902 |
| 2021 | 26 | 7,854 | 16,404 | $1.8M | $742,231 |
| 2020 | 23 | 6,221 | 13,009 | $1.5M | $545,853 |
Total Patients
28,543
Total Services
61,403
Medicare Billing
$2.6M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 855 | 1,375 | $279,195 | $111,417 | 39.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 544 | 949 | $326,456 | $107,856 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,194 | 1,775 | $257,890 | $98,579 | 38.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 902 | 1,171 | $217,618 | $90,042 | 41.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 977 | 1,371 | $155,696 | $48,700 | 31.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 848 | 6,614 | $119,052 | $29,182 | 24.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 383 | 439 | $122,428 | $26,835 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 217 | 217 | $39,720 | $14,310 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $31,766 | $12,110 | 38.1% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 26 | 29 | $23,142 | $9,849 | 42.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 71 | 82 | $23,614 | $9,434 | 40.0% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $7,792 | $3,542 | 45.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 52 | 75 | $11,293 | $2,707 | 24.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 57 | $4,911 | $1,764 | 35.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $4,095 | $1,660 | 40.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 17 | $6,656 | $1,635 | 24.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 16 | 18 | $4,311 | $1,563 | 36.3% |
| 69100 | Biopsy of ear | Office | 2023 | 27 | 27 | $4,482 | $1,502 | 33.5% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $6,004 | $1,392 | 23.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 12 | 12 | $2,430 | $1,025 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 1,075 | 1,736 | $279,496 | $141,786 | 50.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 598 | 1,094 | $376,336 | $125,899 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,461 | 2,164 | $238,040 | $121,907 | 51.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 966 | 1,280 | $206,080 | $100,844 | 48.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 1,191 | 1,661 | $172,984 | $57,617 | 33.3% |
About Dr. Richard White, MD
Dr. Richard White, MD is a Procedural Dermatology healthcare provider based in Rock Hill, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730165465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard White, MD has received a total of $22,750 in payments from pharmaceutical and medical device companies, with $99.99 received in 2024. These payments were reported across 164 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($11,100).
As a Medicare-enrolled provider, White has provided services to 28,543 Medicare beneficiaries, totaling 61,403 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Location Rock Hill, SC
- Active Since 12/15/2005
- Last Updated 02/19/2008
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1730165465
Products in Payments
- RHOFADE (Drug) $6,605
- ACZONE (Drug) $6,446
- PROTOPIC (Drug) $1,000
- COSENTYX (Biological) $328.36
- Humira (Biological) $322.65
- TREMFYA (Drug) $220.52
- Enbrel (Biological) $208.93
- EUCRISA (Drug) $152.99
- Tremfya (Drug) $136.10
- DUPIXENT (Drug) $120.03
- STELARA (Biological) $88.88
- TALTZ (Drug) $86.40
- BOTOX (Biological) $73.21
- Erivedge (Biological) $56.49
- DUPIXENT (Biological) $50.94
- SKYRIZI (Biological) $48.10
- ORACEA (Drug) $40.50
- AMZEEQ (Drug) $29.89
- DUPIXENT DUPILUMAB INJECTION (Biological) $26.44
- REMICADE (Biological) $24.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.